Epidermal growth factor differentially affects integrin-mediated adhesion and proliferation of ACL and MCL fibroblasts.
The anterior cruciate ligament (ACL) and the medial collateral ligament (MCL) are two commonly injured structures in the human knee. While the MCL heals post-traumatically, the ACL does not. Since growth factors play a major role in the proliferation phase of wound healing, we compared the differential effects of epidermal growth factor (EGF) on adhesion and proliferation of ACL and MCL fibroblasts. Using a micropipette/micromanipulator system we found that cells subjected to shorter incubation periods (15 minutes) with EGF (5, 10, 50 ng/ml) showed a general increase in adhesion to the extracellular matrix fibronectin while cells subjected to longer incubation periods (4, 6, 10, and 24 hr) with EGF (5 ng/ml) showed decreases in adhesion. For both incubation durations, MCL fibroblasts displayed a greater change in adhesion than ACL fibroblasts, when compared to control. Investigation of integrin expression showed no fluctuation in cell surface expression of the alpha5 subunit of the FN-binding integrin alpha5beta1 for all EGF (5 ng/ml) incubation times. MCL cells showed a significant increase in proliferation upon stimulation with EGF compared to ACL cells when cultured in FN coated wells. The results found in this study help provide a better understanding of EGF's role in adhesion and proliferation, two events that may contribute to the differential healing response between ACL and MCL fibroblasts. Following exposure to EGF, ACL and MCL cells initially respond by increasing their adhesion strength. MCL cells respond to all concentrations of EGF while ACL cells appear to have a threshold concentration after which EGF effects plataeu. After this initial response period (<10 hr) cells exhibit lower adhesion strength and higher proliferation rate. It is possible that the release from FN serves to enhance the ability of the cells to proliferate. These results may aid in understanding the ligament healing process.
McKean
Jason M
JM
Department of Biology, the Whitaker Institute of Biomedical Engineering, University of California, San Diego, La Jolla 92093-0412, USA.
Hsieh
Adam H
AH
Sung
K L Paul
KL
D000328:Adult; D016118:Anterior Cruciate Ligament / Q000166:cytology*; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects*; D005353:Fibronectins / Q000378:metabolism; D006801:Humans; D016023:Integrins / Q000502:physiology*; D008297:Male; D017888:Medial Collateral Ligament, Knee / Q000166:cytology*; D008875:Middle Aged; D013997:Time Factors
D005353:Fibronectins; D016023:Integrins; D004815:Epidermal Growth Factor